Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2024-03-01 Option Award |
2024-03-04 5:44 pm |
N/A 2034-03-01 |
Aligos Therapeutics Inc. | ALGS | McClure Matthew W. Chief Medical Officer |
72,000 | $0 | 72,000 (Direct) |
View |
| 2024-02-28 Option Award |
2024-02-28 5:33 pm |
N/A 2030-12-01 |
Aligos Therapeutics Inc. | ALGS | McClure Matthew W. Chief Medical Officer |
157,324 | $0 | 157,324 (Direct) |
View |
| 2023-09-08 Option Award |
2023-09-12 4:08 pm |
N/A 2033-09-08 |
Aligos Therapeutics Inc. | ALGS | McClure Matthew W. Chief Medical Officer |
48,000 | $0 | 48,000 (Direct) |
View |
| 2023-03-15 Option Award |
2023-03-17 4:12 pm |
N/A 2033-03-15 |
Aligos Therapeutics Inc. | ALGS | McClure Matthew W. Chief Medical Officer |
75,000 | $0 | 75,000 (Direct) |
View |
| 2022-07-07 Option Award |
2022-07-11 4:15 pm |
N/A 2032-07-07 |
Aligos Therapeutics Inc. | ALGS | McClure Matthew W. Chief Medical Officer |
46,000 | $0 | 46,000 (Direct) |
View |
Ownership |
2022-05-06 4:12 pm |
N/A N/A |
Aligos Therapeutics Inc. | ALGS | McClure Matthew W. Chief Medical Officer |
0 | $0 | 515,478 (Indirect) |
View |